Roberto Alejandro Sica, MD, a Hematologist-Oncologist with Montefiore Medical Center
Get to know Hematologist-Oncologist Dr. Roberto Alejandro Sica, who serves patients in Bronx, New York.
More on YorkPedia:
- Micart is Winning Hearts with Their Exceptional Rock Music
- Music Promotion Club Collecting Appreciation For The Best Promotional Options For YouTube Videos
- Brilliant Facets Offered by the Best Press Release Submission Sites
- Write and Promote Press Releases from IssueWire to Achieve Immense Growth
- Listen to the Latest Song ‘Black Dog’ by Billy Scott
(YorkPedia Editorial):- New York City, New York Jan 4, 2022 (Issuewire.com) – An exceptional hematologist-oncologist, Dr. Sica is a member of the Hematologic Malignancy Team and the Bone Marrow Transplant Team at Montefiore Medical Center in Bronx, New York. He also serves as an Assistant Professor of Medicine at the Albert Einstein College of Medicine.
Since joining the Montefiore team, his clinical focus has been on chimeric antigen receptor (CAR) T-cell therapies, immunotherapies and allogeneic stem cell transplantation, central nervous system (CNS) lymphomas and HIV, ATLL, and gene therapy for malignant and nonmalignant hematologic disorders.
Academically, Dr. Sica received his medical degree from the University of Buenos Aires School of Medicine. During his time there, he also served as an instructor of immunology, virology, pharmacology, and physical diagnosis. He began his postgraduate training with a residency in internal medicine at the Carney Hospital/Tufts University School of Medicine in Boston. Following this, he completed a fellowship in Hematology/Oncology at the University of Illinois at Chicago, where he received the E. Donnall Thomas Achievement in Medicine Award for his academic performance and the Edward Jenner Innovation in Medicine Award in recognition of his innovative contributions to the design of clinical protocols and trials.
Later, he completed a fellowship in blood and marrow transplant and cellular therapies at Stanford University. At that institution, he performed research with Dr. Sally Arai on Hodgkin’s lymphoma using the Stanford-pioneered GN-BVC regimen (Gemcitabine, Vinorelbine-BCNU. Etoposide, and Cyclophosphamide) which resulted in decreased toxicity and improved overall survival in patients. His work has been published in various review journals and abstracts.
As a testament to his continued education, the doctor is board-certified in hematology, medical oncology, and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.
An avid researcher, Dr. Sica’s research focuses on novel cellular therapies, allogeneic bone marrow transplantation for malignant and nonmalignant hematologic disorders, and combination immunotherapy and cancer vaccine.
Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.
Learn More about Dr. Roberto Alejandro Sica:
Through his findatopdoc profile, https://www.findatopdoc.com/doctor/292358-Roberto-Sica-Internist or through Montefiore Medical Center, https://www.montefiore.org/body.cfm?id=3108&action=detail&ref=19684
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know-how to make informed decisions for you and your family.
Your Health Contact
This article was originally published by IssueWire. Read the original article here.